Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Hungary Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20101
20153
20161
20171
20182
20193
20203
20212
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting8
Recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Pfizer2
Basilea Pharmaceutica1
BicycleTx Limited1
Daiichi Sankyo1
G1 Therapeutics, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms24
Carcinoma, Transitional Cell7
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms4
Ovarian Neoplasms4
Prostatic Neoplasms4
Breast Neoplasms3
Endometrial Neoplasms3
Urethral Neoplasms3
Uterine Cervical Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.